Baran, A.; Stepaniuk, A.; Kiluk, P.; Kaminski, T.W.; Maciaszek, M.; Flisiak, I.
Potential Predictive Value of Serum Pentraxin 3 and Paraoxonase 1 for Cardiometabolic Disorders Development in Patients with Psoriasis—Preliminary Data. Metabolites 2022, 12, 580.
https://doi.org/10.3390/metabo12070580
AMA Style
Baran A, Stepaniuk A, Kiluk P, Kaminski TW, Maciaszek M, Flisiak I.
Potential Predictive Value of Serum Pentraxin 3 and Paraoxonase 1 for Cardiometabolic Disorders Development in Patients with Psoriasis—Preliminary Data. Metabolites. 2022; 12(7):580.
https://doi.org/10.3390/metabo12070580
Chicago/Turabian Style
Baran, Anna, Anna Stepaniuk, Paulina Kiluk, Tomasz W. Kaminski, Magdalena Maciaszek, and Iwona Flisiak.
2022. "Potential Predictive Value of Serum Pentraxin 3 and Paraoxonase 1 for Cardiometabolic Disorders Development in Patients with Psoriasis—Preliminary Data" Metabolites 12, no. 7: 580.
https://doi.org/10.3390/metabo12070580
APA Style
Baran, A., Stepaniuk, A., Kiluk, P., Kaminski, T. W., Maciaszek, M., & Flisiak, I.
(2022). Potential Predictive Value of Serum Pentraxin 3 and Paraoxonase 1 for Cardiometabolic Disorders Development in Patients with Psoriasis—Preliminary Data. Metabolites, 12(7), 580.
https://doi.org/10.3390/metabo12070580